Michelle M Foisy

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
    M M Foisy
    Royal Alexandra Hospital, Northern Alberta HIV Program, Edmonton, Alberta, Canada
    HIV Med 9:389-96. 2008
  2. ncbi Induction effects of ritonavir: implications for drug interactions
    Michelle M Foisy
    Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:1048-59. 2008
  3. ncbi Abacavir hypersensitivity reaction: an update
    Christine A Hughes
    Faculty of Pharmacy and Pharmaceutical Sciences, HIV, Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Region, Edmonton, Alberta, Canada
    Ann Pharmacother 42:387-96. 2008
  4. ncbi Complexity of interactions between voriconazole and antiretroviral agents
    Erin M Yakiwchuk
    Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:698-703. 2008
  5. ncbi Adverse effects of antiretrovirals in HIV-infected pregnant women
    Dalyce M Zuk
    Regional Pharmacy Services, Capital Health, Edmonton, Alberta, Canada
    Ann Pharmacother 43:1028-35. 2009
  6. ncbi Pharmaceutical care for HIV patients on directly observed therapy
    Michelle M Foisy
    Northern Alberta HIV Program, Royal Alexandra Hospital and DOT for HAART Program, Boyle McCauley Health Centre, Edmonton, Alberta, Canada
    Ann Pharmacother 38:550-6. 2004

Detail Information

Publications6

  1. ncbi Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
    M M Foisy
    Royal Alexandra Hospital, Northern Alberta HIV Program, Edmonton, Alberta, Canada
    HIV Med 9:389-96. 2008
    ..The clinical presentation, diagnosis and management will be discussed...
  2. ncbi Induction effects of ritonavir: implications for drug interactions
    Michelle M Foisy
    Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:1048-59. 2008
    ..To review the literature on the induction effects of ritonavir on the cytochrome P450 enzyme system and glucuronyl transferase and identify resultant established and potential drug interactions...
  3. ncbi Abacavir hypersensitivity reaction: an update
    Christine A Hughes
    Faculty of Pharmacy and Pharmaceutical Sciences, HIV, Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Region, Edmonton, Alberta, Canada
    Ann Pharmacother 42:387-96. 2008
    ..To review the clinical features, risk factors, diagnosis, and management of abacavir hypersensitivity reaction (HSR)...
  4. ncbi Complexity of interactions between voriconazole and antiretroviral agents
    Erin M Yakiwchuk
    Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:698-703. 2008
    ..To evaluate and summarize pertinent aspects of the literature on interactions between voriconazole and antiretroviral agents...
  5. ncbi Adverse effects of antiretrovirals in HIV-infected pregnant women
    Dalyce M Zuk
    Regional Pharmacy Services, Capital Health, Edmonton, Alberta, Canada
    Ann Pharmacother 43:1028-35. 2009
    ..It is unclear whether the risk of ARV-related adverse drug reactions (ADRs) is increased during pregnancy...
  6. ncbi Pharmaceutical care for HIV patients on directly observed therapy
    Michelle M Foisy
    Northern Alberta HIV Program, Royal Alexandra Hospital and DOT for HAART Program, Boyle McCauley Health Centre, Edmonton, Alberta, Canada
    Ann Pharmacother 38:550-6. 2004
    ..A multidisciplinary team including the pharmacist can impact upon the delivery of care to the inner-city HIV patient population...